SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 14 filers reported holding SUMMIT THERAPEUTICS PLC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $24,000 | -17.2% | 11,000 | -7.6% | 0.00% | – |
Q2 2018 | $29,000 | -81.2% | 11,900 | 0.0% | 0.00% | – |
Q1 2018 | $154,000 | +450.0% | 11,900 | +376.0% | 0.00% | – |
Q4 2017 | $28,000 | -9.7% | 2,500 | 0.0% | 0.00% | – |
Q3 2017 | $31,000 | +10.7% | 2,500 | 0.0% | 0.00% | – |
Q2 2017 | $28,000 | – | 2,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Granite Point Capital Management, L.P. | 127,841 | $1,331,000 | 0.91% |
SPHERA FUNDS MANAGEMENT LTD. | 205,200 | $2,136,000 | 0.27% |
LANSDOWNE PARTNERS (UK) LLP | 930,000 | $9,681,000 | 0.08% |
Point72 Asset Management, L.P. | 919,639 | $9,573,000 | 0.08% |
EverPoint Asset Management, LLC | 100,000 | $1,041,000 | 0.03% |
AXA S.A. | 376,205 | $3,916,000 | 0.02% |
First Eagle Investment Management, LLC | 175,000 | $1,822,000 | 0.01% |
Tower Research Capital LLC (TRC) | 1,228 | $13,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 2,500 | $26,000 | 0.00% |
MORGAN STANLEY | 9 | $0 | 0.00% |